The drug, nirsevimab, was effective against respiratory syncytial virus infections when used in the Yukon-Kuskokwim Delta, a ...

RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...

There has been a "dramatic" decrease in cases of RSV among babies due to a new vaccine but flu is rising and expected to peak after Christmas, the interim chief medical officer said. Usually one in ...

Nirsevimab has been hailed by Sanofi chief executive Paul Hudson as one of the brightest prospects in the company's pipeline, providing a brand new way to tackle RSV, which according to the World ...

Respiratory syncytial virus (RSV) is an infectious respiratory disease that can look and sound a lot like a cold, with ...

At a meeting to present its vaccines pipeline to investors today, the French pharma is highlighting the potential of Beyfortus (nirsevimab) for the protection of infants in their first RSV season ...

SummaryState warns of rising COVID threat, surge in Whooping Cough cases The Illinois Department of Public Health is ...

Becoming a new parent brings plenty of challenges, and getting your young children all the vaccines they need, when they need ...

Yesterday, officials in British Columbia (BC) reported a fourth case of chronic wasting disease (CWD) in the Kootenay region ...

Health officials in Vietnam's Long An province today reported a human H5 case involving an 18-year-old man who is ...

South Korean Leader’s Fate Is in Doubt as Lawmakers Move to Impeach Him The effort to remove President Yoon Suk Yeol reflected fury over his declaration of martial law. He lifted the order ...